decorative image
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
decorative image
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

n/a Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.

Weekly NIH Funding Opportunities and Notices
July 13, 2018

General Notices

Funding Opportunities

  • Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional)
    (PA-18-849)
    National Institute of Nursing Research
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional)
    (PA-18-850)
    National Institute of Nursing Research
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trials Optional)
    (PA-18-851)
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt Date(s): December 11, 2018, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)
    (PAR-18-853)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): November 27, 2018, November 27, 2019, November 27, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
    (PAR-18-854)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Cancer Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Office of Behavioral and Social Sciences Research
    Office of Disease Prevention
    Application Receipt Date(s): August 23, 2018; September 13, 2018; October 10, 2018; November 13, 2018; December 11, 2018; January 10, 2019; February 11, 2019; March 11, 2019; April 11, 2019; May 10, 2019; June 10, 2019; July 11, 2019; August 9, 2019; September 12, 2019; October 11, 2019; November 13, 2019; December 10, 2019; January 10, 2020; February 10, 2020; March 10, 2020; April 7, 2020; May 11, 2020; June 10, 2020; July 10, 2020; August 11, 2020; September 10, 2020; October 14, 2020; November 10, 2020; December 11, 2020; January 11, 2021; February 10, 2021; March 10, 2021; April 9, 2021; May 10, 2021; June 11, 2021; July 9, 2021; August 10, 2021; September 10, 2021 by 5:00 PM local time of applicant organization.
  • Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)
    (RFA-AI-18-036)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): January 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource Registry (U24 Clinical Trial Not Allowed)
    (RFA-DC-19-002)
    National Institute on Deafness and Other Communication Disorders
    Application Receipt Date(s): October 23, 2018; June 24 , 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed)
    (RFA-DE-19-004)
    National Institute of Dental and Craniofacial Research
    Application Receipt Date(s): October 4, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.